IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry's Broadest Injectable Aesthetics Portfolio
Businesswire·2026-01-22 06:00
Core Insights - Galderma will present ten posters showcasing updates from its aesthetic portfolio at the IMCAS 2026 World Congress in Paris, focusing on regenerative biostimulation, HA, and neuromodulator treatments [1] - The company will emphasize its leadership in community education through various events, including two symposia and a live anatomy workshop [1]